Evidence map›Paper›PMID 23136059›Full record

ArticleInternational journal of cancer2013

Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations.

Paul K S Chan, Chuqing Zhang, Jong-Sup Park, Karen K Smith-McCune, Joel M Palefsky, Lucia Giovannelli, Francois Coutlée, Samantha Hibbitts, Ryo Konno, Wannapa Settheetham-Ishida and 22 more

Abstract readComparative Study
In one paragraph

Article in International journal of cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Human Papillomavirus (HPV) Prevalence and Type Distribution in Urban Areas of Malaysia.Asian Pacific journal of cancer prevention : APJCP · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The contribution of Latin American research to HPV epidemiology and natural history knowledge.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2020
    Review
  17. Article
  18. Article
  19. Oncogenic comparison of human papillomavirus type 58 E7 variants.Journal of cellular and molecular medicine · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Paul K S ChanDepartment of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China. paulkschan@cuhk.edu.hk
Chuqing Zhang
Jong-Sup Park
Karen K Smith-McCune
Joel M Palefsky
Lucia Giovannelli
Francois Coutlée
Samantha Hibbitts
Ryo Konno
Wannapa Settheetham-Ishida
Tang-Yuan Chu
Annabelle Ferrera
María Alejandra Picconi
Federico De Marco
Yin-Ling Woo
Tainá Raiol
Patricia Piña-Sánchez
Jeong-Hoon Bae
Martin C S Wong
Mike Z Chirenje
Tsitsi Magure
Anna-Barbara Moscicki
Alison N Fiander
Giuseppina Capra
Eun Young Ki
Yi Tan
Zigui Chen
Robert D Burk
Martin C W Chan
Tak-Hong Cheung
David Pim
Lawrence Banks

Funding

Natural History of HPV Infection to NeoplasiaR37CA051323 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MOSCICKI, ANNA-BARBARA · 2005 to 2014
$15.4M
PERSISTENT HUMAN PAPILLOMAVIRUS IN WOMEN AT RISK FOR CERVIX CANCERU01CA078527 · NCI · YESHIVA UNIVERSITY · PI BURK, ROBERT D · 2003 to 2018
$8.6M
PERSISTENT HPV IN WOMEN AT RISK FOR CERVIX CANCERR01CA078527 · NCI · YESHIVA UNIVERSITY · PI BURK, ROBERT D. · 1998 to 2002
$1.5M
NCI NIH HHS R01 CA078527NCI NIH HHS R37 CA051323NCI NIH HHS U01 CA078527
6 · The paper itself

Abstract

Human papillomavirus (HPV) 58 accounts for a notable proportion of cervical cancers in East Asia and parts of Latin America, but it is uncommon elsewhere. The reason for such ethnogeographical predilection is unknown. In our study, nucleotide sequences of E6 and E7 genes of 401 HPV58 isolates collected from 15 countries/cities across four continents were examined. Phylogenetic relationship, geographical distribution and risk association of nucleotide sequence variations were analyzed. We found that the E6 genes of HPV58 variants were more conserved than E7. Thus, E6 is a more appropriate target for type-specific detection, whereas E7 is more appropriate for strain differentiation. The frequency of sequence variation varied geographically. Africa had significantly more isolates with E6-367A (D86E) but significantly less isolates with E6-203G, -245G, -367C (prototype-like) than other regions (p ≤ 0.003). E7-632T, -760A (T20I, G63S) was more frequently found in Asia, and E7-793G (T74A) was more frequent in Africa (p < 0.001). Variants with T20I and G63S substitutions at E7 conferred a significantly higher risk for cervical intraepithelial neoplasia grade III and invasive cervical cancer compared to other HPV58 variants (odds ratio = 4.44, p = 0.007). In conclusion, T20I and/or G63S substitution(s) at E7 of HPV58 is/are associated with a higher risk for cervical neoplasia. These substitutions are more commonly found in Asia and the Americas, which may account for the higher disease attribution of HPV58 in these areas.

Indexed as

Biomarkers, TumorCapsid ProteinsCervix UteriDNA, NeoplasmFemaleFollow-Up StudiesGenetic VariationGeographyHumansInternational AgenciesOncogene Proteins, ViralPapillomaviridaePapillomavirus E7 ProteinsPapillomavirus InfectionsPhylogenyPolymerase Chain ReactionBiomarkers, TumorCapsid ProteinsDNA, NeoplasmE6 protein, human papillomavirus type 58Oncogene Proteins, ViralPapillomavirus E7 Proteins

Identifiers

PMID23136059
PMCPMC3962828

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.